Holen Sie sich die Stockscreener-App
12.57
0.16%
-0.02
Handel nachbörslich:
12.50
-0.07
-0.56%
Schlusskurs vom Vortag:
$12.59
Offen:
$12.58
24-Stunden-Volumen:
9.30M
Relative Volume:
1.60
Marktkapitalisierung:
$8.58B
Einnahmen:
$125.68M
Nettoeinkommen (Verlust:
$4.81B
KGV:
2.2248
EPS:
5.65
Netto-Cashflow:
$-781.21M
1W Leistung:
+5.28%
1M Leistung:
+9.21%
6M Leistung:
+21.80%
1J Leistung:
+6.98%
1-Tages-Spanne:
$12.53
$13.08
1-Wochen-Bereich:
$11.85
$13.08
52-Wochen-Spanne:
$8.73
$13.08
Roivant Sciences Ltd Stock (ROIV) Company Profile
Firmenname
Roivant Sciences Ltd
Sektor
Branche
Telefon
441-295-5950
Adresse
7TH FLOOR, 50 BROADWAY, LONDON
Vergleichen Sie ROIV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
12.57 | 8.46B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-01-05 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Eingeleitet | Guggenheim | Buy |
| 2023-06-08 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-27 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2022-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Eingeleitet | Goldman | Buy |
| 2021-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-28 | Eingeleitet | Citigroup | Buy |
| 2021-10-26 | Eingeleitet | Cowen | Outperform |
| 2021-10-26 | Eingeleitet | Jefferies | Buy |
| 2021-10-26 | Eingeleitet | Truist | Buy |
Alle ansehen
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Transcript : Roivant Sciences Ltd.Special Call - MarketScreener
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients - GlobeNewswire Inc.
Using RSI to spot recovery in Roivant Sciences Ltd.July 2025 Pullbacks & Free Growth Oriented Trading Recommendations - Newser
Short interest data insights for Roivant Sciences Ltd.July 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
Published on: 2025-09-03 09:05:20 - Newser
Technical analysis overview for Roivant Sciences Ltd. stock2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Is Roivant Sciences Ltd. stock bottoming outJuly 2025 Short Interest & AI Powered Market Entry Ideas - Newser
Real time pattern detection on Roivant Sciences Ltd. stockJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - Newser
Is Roivant Sciences Ltd. forming a reversal patternEarnings Summary Report & AI Driven Stock Movement Reports - Newser
What machine learning models say about Roivant Sciences Ltd.Weekly Stock Summary & Expert Approved Momentum Trade Ideas - Newser
Can swing trading help recover from Roivant Sciences Ltd. losses2025 Key Lessons & Daily Technical Forecast Reports - Newser
Order flow analysis tools used on Roivant Sciences Ltd.2025 Dividend Review & Weekly Top Gainers Alerts - Newser
Will a bounce in Roivant Sciences Ltd. offer an exitJuly 2025 PreEarnings & Weekly High Momentum Picks - Newser
Combining price and volume data for Roivant Sciences Ltd.Trade Analysis Report & Growth Oriented Trade Recommendations - Newser
How institutional ownership impacts Roivant Sciences Ltd. stockJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Roivant Sciences Ltd. stock daily chart insightsJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - Newser
Citi Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $16 - 富途牛牛
Citigroup initiates coverage on Roivant Sciences with Buy rating and $16 price target. - AInvest
How to monitor Roivant Sciences Ltd. with trend dashboardsWeekly Market Report & Capital Efficiency Focused Ideas - Newser
Will Roivant Sciences Ltd. bounce back from current supportEarnings Recap Summary & Daily Entry Point Alerts - Newser
Trading Bots Trigger Alerts on Roivant Sciences Ltd. Activity getLinesFromResByArray error: size == 0 - thegnnews.com
Automated trading signals detected on Roivant Sciences Ltd.Quarterly Growth Report & Low Drawdown Trading Strategies - Newser
How to use Fibonacci retracement on Roivant Sciences Ltd.Portfolio Return Report & Safe Entry Zone Identification - Newser
Analyzing Roivant Sciences Ltd. with risk reward ratio chartsJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - Newser
Chart overlay techniques for tracking Roivant Sciences Ltd.Stop Loss & Verified Stock Trade Ideas - Newser
Building trade automation scripts for Roivant Sciences Ltd.Global Markets & Proven Capital Preservation Tips - Newser
Identifying reversal signals in Roivant Sciences Ltd.July 2025 Fed Impact & AI Driven Price Forecasts - Newser
Forecasting Roivant Sciences Ltd. price range with options data2025 Price Momentum & Daily Market Momentum Tracking - Newser
Can a trend reversal in Roivant Sciences Ltd. lead to recoveryPortfolio Risk Report & Reliable Entry Point Alerts - Newser
Applying Elliott Wave Theory to Roivant Sciences Ltd.July 2025 Trade Ideas & Stock Portfolio Risk Management - Newser
News impact scoring models applied to Roivant Sciences Ltd.Market Trend Summary & Free Weekly Watchlist of Top Performers - Newser
Tools to monitor Roivant Sciences Ltd. recovery probability2025 Investor Takeaways & Daily Price Action Insights - Newser
Is Roivant Sciences Ltd. stock a good hedge against inflationJuly 2025 Opening Moves & Expert Curated Trade Setups - Newser
Roivant Sciences (ROIV) Announces Q1 2025 Business Update - MSN
Will Roivant Sciences Ltd. rebound enough to break evenJuly 2025 PreEarnings & Community Shared Stock Ideas - Newser
How high can Roivant Sciences Ltd. stock goMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Roivant Sciences Ltd-Aktie (ROIV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Venker Eric | President & Immunovant CEO |
Aug 20 '25 |
Sale |
11.72 |
100,000 |
1,172,000 |
1,653,585 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):